In this context, the inhibition of CI by metformin did not affect the metastatic potential of cancer cells since high levels of PGC‐1α support it by promoting glycolytic metabolism and diverting mitochondrial metabolites usually employed for OXPHOS‐dependent ATP production toward anabolic reactions [65]. The gene discussed is PPARGC1A; the disease is cancer.